Ocrevus Zunovo

Active Ingredient(s): Ocrelizumab + Hyaluronidase-ocsq
FDA Approved: * September 13, 2024
Pharm Company: * GENENTECH INC
Category: Multiple Sclerosis
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ocrevus Zunovo Subcutaneous Injection, Solution

NDC: 50242-554

Labeler:

Genentech, Inc.

Popular Topics

Ocrevus - Burning skin sensation

Has anyone experienced a burning skin sensation from Ocrevus? For me, it is occurring in my back and buttocks. It is wor...

2 REPLIES

Ocrevus infusion time to take effect

How long do I have to wait for the medicine take effect? I still have a migraine and dizziness every day. I first infusi...

2 REPLIES

Ocrevus AWP pricing

I am trying to locate the AWP for Ocrevus. Any ideas? I have not been able to locate it anywhere. Thank you. ## Hi Nan, ...

1 REPLY